DBCO-acid

CAT:
804-HY-42972-01
Size:
10 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
DBCO-acid - image 1

DBCO-acid

  • Description:

    DBCO-acid is a click chemistry reagent used in the synthesis of ADC linker DBCO-NHS ester ((HY-115524) and (HY-115545) ), and agent-linker conjugates DBCO-PEG-MMAE (HY-111012 and HY-126690) . DBCO-acid contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups[1][2][3][4].
  • UNSPSC:

    12352203
  • Hazard Statement:

    H302, H315, H319, H335
  • Target:

    Biochemical Assay Reagents
  • Type:

    ADC Related
  • Related Pathways:

    Others
  • Applications:

    Cancer-programmed cell death
  • Field of Research:

    Cancer
  • Assay Protocol:

    https://www.medchemexpress.com/dbco-acid.html
  • Purity:

    99.71
  • Solubility:

    DMSO : 100 mg/mL (ultrasonic)
  • Smiles:

    O=C(CCC(O)=O)N(C1)C2=C(C=CC=C2)C#CC3=C1C=CC=C3
  • Molecular Formula:

    C19H15NO3
  • Molecular Weight:

    305.33
  • Precautions:

    H302, H315, H319, H335
  • References & Citations:

    [1]Zimmerman ES, et al. Production of site-specific antibody-drug conjugates using optimized non-natural amino acids in a cell-free expression system. Bioconjug Chem. 2014 Feb 19;25 (2) :351-61.|[2]Klein PM, et al. Click-Shielded and Targeted Lipopolyplexes. Methods Mol Biol. 2019;2036:141-164.|[3]Wang M, et al. Transforms of Cell Surface Glycoproteins Charge Influences Tumor Cell Metastasis via Atypically Inhibiting Epithelial-Mesenchymal Transition Including Matrix Metalloproteinases and Cell Junctions. Bioconjug Chem. 2023 Aug 16;34 (8) :1498-1507. |[4]Klein PM, et al. Folate receptor-directed orthogonal click-functionalization of siRNA lipopolyplexes for tumor cell killing in vivo. Biomaterials. 2018 Sep;178:630-642.
  • Shipping Conditions:

    Room Temperature
  • Storage Conditions:

    4°C (Powder, stored under nitrogen)
  • Scientific Category:

    ADC Related
  • Clinical Information:

    No Development Reported
  • CAS Number:

    [1353016-70-2]